Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
FOXO4-DRI represents a peptide-based senolytic approach that is more targeted than small-molecule senolytics like dasatinib plus quercetin, which affect broader cellular pathways
It is considered to be a sterile diluent and not an active pharmaceutical drug
Take a mitochondrial peptide like Mots-c
Fine for larger doses, but problematic if you need 100 mcg, because 100 mcg would be just 0.02 mL, or 2 units on the syringe
Proposed by GH-axis researchers to support lean body mass and body-composition changes, though this claim rests on GH and IGF-1's known physiological roles rather than on direct body-composition trials of CJC-1295 itself
US$ 22.78
/assets/production/practices/3280152d22c7599df4208c7f13bd6f106ba2a939/images/2788238.jpeg)
US$ 22.97
US$ 25.26
.png)
US$ 24.69
